T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Keros Therapeutics
KROS
$211M
| $51M | 0.01% |
1,270,361
+117,845
| +10% | +$5.17M |
|
702
D.R. Horton
DHI
$41.9B
| $50.9M | 0.01% |
417,938
-3,704
| -0.9% | -$405K |
|
703
Diodes
DIOD
$4.48B
| $50.9M | 0.01% |
549,797
+4,463
| +0.8% | +$393K |
|
|
SAGE
704
DELISTED
Sage Therapeutics
SAGE
| $50.8M | 0.01% |
1,080,153
-828,238
| -43% | -$41.2M |
|
705
Dow Inc
DOW
$21.9B
| $50.6M | 0.01% |
949,497
-3,168
| -0.3% | -$168K |
|
706
Armstrong World Industries
AWI
$7.68B
| $49.9M | 0.01% |
679,435
+1,424
| +0.2% | +$96.9K |
|
707
CRISPR Therapeutics
CRSP
$5.22B
| $49.5M | 0.01% |
882,375
-220,346
| -20% | -$12.5M |
|
708
KKR & Co
KKR
$103B
| $49.2M | 0.01% |
878,176
-232,500
| -21% | -$12.2M |
|
|
SNCY
709
DELISTED
Sun Country Airlines
SNCY
| $49.1M | 0.01% |
2,185,127
+47,162
| +2% | +$901K |
|
|
SEE
710
DELISTED
Sealed Air
SEE
| $49M | 0.01% |
1,224,415
-58,033
| -5% | -$2.47M |
|
711
Crocs
CROX
$6.36B
| $48.9M | 0.01% |
434,968
-132,603
| -23% | -$15.8M |
|
712
Fortive
FTV
$18.7B
| $48.7M | 0.01% |
864,633
-36,628
| -4% | -$1.85M |
|
713
Axalta
AXTA
$7.93B
| $48.6M | 0.01% |
1,481,450
+79,444
| +6% | +$2.47M |
|
714
Seadrill
SDRL
$2.94B
| $48.6M | 0.01% |
1,177,428
+138,937
| +13% | +$5.16M |
|
715
Kinsale Capital Group
KNSL
$8.59B
| $48.4M | 0.01% |
129,215
+120,647
| +1,408% | +$40M |
|
716
ATI
ATI
$30.9B
| $48.1M | 0.01% |
1,086,562
+373,568
| +52% | +$14.3M |
|
717
Matador Resources
MTDR
$6.39B
| $48M | 0.01% |
918,147
-66,954
| -7% | -$3.23M |
|
718
Coca-Cola Consolidated
COKE
$12.7B
| $47.9M | 0.01% |
753,190
+3,390
| +0.5% | +$210K |
|
|
SGI
719
Somnigroup International
SGI
$14B
| $47.7M | 0.01% |
1,190,425
-29,075
| -2% | -$1.09M |
|
720
JD.com
JD
$39.6B
| $47.5M | 0.01% |
1,393,196
+114,556
| +9% | +$4.17M |
|
721
Littelfuse
LFUS
$11.4B
| $47.5M | 0.01% |
163,216
+394
| +0.2% | +$103K |
|
722
CBIZ
CBZ
$2.96B
| $47.5M | 0.01% |
891,425
+38,770
| +5% | +$1.99M |
|
723
Simply Good Foods
SMPL
$989M
| $47.5M | 0.01% |
1,297,638
-161,680
| -11% | -$5.95M |
|
724
W.W. Grainger
GWW
$62.2B
| $47.3M | 0.01% |
59,951
-554
| -0.9% | -$381K |
|
725
Alkermes
ALKS
$8.3B
| $47.2M | 0.01% |
1,509,446
-33,905
| -2% | -$1.03M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.